Nephrology Now (@nephrologynow) profile picture

Keeping up to date with Nephrology

Joined August 2009
FLOW adds semaglutide as another therapy that meaningfully slows progression of CKD, while also lowering mortality, in patients with diabetes and proteinuric CKD
Presented at #ERA24: FLOW trial: In patients with type 2 diabetes and chronic kidney disease, weekly semaglutide significantly reduced risks of major kidney events, cardiovascular events, and death from any cause while slowing loss of kidney function. nej.md/44U3slP
1
1
1
1
1,257
Great thread on @BEST_CLI study which included 11% patients on dialysis
Replying to @drdschwartzmd
Is @BEST_CLI relevant in patients with kidney disease or dialysis? 11% of pts on dialysis! Cohort 1, subgroup analysis on dialysis vs not (small numbers) did not show benefit Stop you applying result to dialysis pts? @Ask_Renal @kidney_boy @hswapnil @NephJC @VascularSVS
596
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia from @NEJM by @BEST_CLI - critically important study given the burden of peripheral vascular disease (>200 million globally) What did the study find? 1/x nejm.org/doi/full/10.1056/NE…
1
10
1
15
7,235
Chlorthalidone did not lead to a lower incidence of major cardiovascular outcomes or non–cancer-related deaths than hydrochlorothiazide ⁦@NEJM⁩
6
19
Insights to Guide Early Recognition and Linkage to Care in AL Amyloidosis with ⁦@UBCmedicine⁩ faculty Produced by ⁦@PeerVoice⁩ ca.peervoice.com/240200965/2…
1
2
2
Such an important paper to discuss & share Too often we see emotional response to slowly declining GFR leading discontinuation of ACEi/ARB We need to remind colleagues - declining GFR happens despite the standard of care. Without treatment, pts would just get worse even faster
1
6
7 most impactful clinical trials focussed on slowing progression of chronic kidney disease A Thread 🧵 A highly subjective list, but these trials have been included as they have had a meaningful impact on guidelines, patients and clinicians at a global scale.
2
57
5
119
7 ways the EMPA-KIDNEY trial will impact clinical care in CKD A Thread 🧵 Sources @NEJM @NephJC @DiabetesCanada @AmDiabetesAssn @goKDIGO @ESC_Journals @hswapnil @kidney_boy
5
149
18
393
>80% ready to offer triple therapy with ACEi/ARB, SGLTi & Finerenone in patients with T2D, CKD and persistent proteinuria
Replying to @drdschwartzmd
Would you add finerenone to patients w/ diabetes, CKD and persistent proteinuria ( w/ normal K+) despite RAASi & SGLT2i & lifestyle changes (ie offer triple therapy)?
83%Yes
8%No
10%See comment
183 votes • Final results
7 Practical Tips for Starting an SGLT2 Inhibitor A Thread 🧵 SGLT2i inhibitors (eg empagliflozin, dapagliflozin, canagliflozin) have a phenomenal evidence base and have been shown to be beneficial in diabetes, heart disease (particularly heart failure) and kidney disease. 1/x
1
3
1
8
Should patients w/ diabetes, CKD and proteinuria despite RAASi & SGLT2i be considered for add-on therapy with finerenone (triple therapy)? A thread 🧵 & survey (see end) Sources @NEJM @NephJC @goKDIGO @ESC_Journals @CADTH_ACMTS
2
39
68
Minimizing the risk of COVID-19 among patients on dialysis. qxmd.com/r/32249840
1
1
If you are a healthcare worker or #firstresponder, watch this 20 second video. And know they are cheering for you. youtu.be/va7PF9eE-tw You have the whole world behind you. #HealthcareHeroes #Cheer4HealthWorkers #WeApplaud
3
1
A web-based app was developed to calculate the risk of primary endpoints in patients with newly diagnosed IgA nephropathy. The app can be found at @QxMD or here: qxmd.com/calculate/calculato… #NephJC
1
3
8
Papers worth reading in Nephrology
5
1
Use this predictive model in CKD prognosis on Calculate by @QxMD qxmd.com/calculate/calculato…
Great article: Derivation and validation of a prognostic model to predict mortality in patients with adva... QxMD.com/r/30395311 #ReadByQxMD
2
3
Get the ADPKD risk calculator on your mobile device via Calculate by QxMD qxmd.com/calculate/calculato… – at New Westminster, British Columbia
Loving the ADPKD risk calculator powered by @qxmd. Includes a handy graph to automatically plot a patient’s estimated risk: ukidney.com/nephrology-res… teapawt.net/UKidney/status/1027210…
1
3
4